Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the ...

If you use insulin and find it challenging to get dosing just right — and let’s face it, that can be hard — then you may want to know about new technology underway called the artificial pancreas ...

A recent paper published in Diabetes Technology & Therapeutics describes the design, safety and basic efficacy of a device-agnostic smartphone app that can interface with continuous glucose monitors, ...

Adding advanced artificial intelligence to an artificial pancreas regulating type 1 diabetes is safe and improves the system’s efficiency, a first-of-its-kind study from the University of Virginia ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A fully ...

Researchers in the US have designed an interactive artificial pancreas system that uses digital twin technology to control type 1 diabetes, showing promising results in early trials. Designed by ...

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod ® Insulin Management System (OmniPod System), today announced a license agreement and partnership ...

Mere weeks after announcing the first insulin pump partner for its FreeStyle Libre 2 Plus continuous glucose monitor—in which the “Plus” designates an FDA-cleared ability to link up with automated ...

Four studies backed by the National Institutes of Health have either launched or are poised to launch in the near future. Researchers hope these studies will serve as the potential bridge between ...

In the not-so-distant future, the hottest new tech on the playground could be an artificial pancreas system. A closed-loop system that combines Dexcom’s continuous glucose monitor with Tandem Diabetes ...

The findings, said the researchers, are an important step toward achieving glucose control with a fully automated closed-loop system for patients with type 1 diabetes. For the first time, researchers ...